SCHEMBL3401461

SCHEMBL3401461

CCOC(=O)c1nc(-c2ccc(F)cc2)c2snc(-c3ccccc3)c2c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
NPSR1 Q6W5P4 4/20 0.51
HPGD P15428 3/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.51
MAPK1 P28482 2/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
PKM P14618 1/20 0.51
HSD17B10 Q99714 1/20 0.45
TRPM8 Q7Z2W7 2/20 0.44
MMP1 P03956 1/20 0.43
MMP13 P45452 1/20 0.43
RARA P10276 1/20 0.43
RARB P10826 1/20 0.43
RARG P13631 1/20 0.43
TP53 P04637 1/20 0.42
TARBP2 Q15633 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407275 1.00 ALDH1A1 (0.51) ALDH1A1NPSR1HPGDKDM4EMAPT
SCHEMBL3398759 0.90 KDM4E (0.54) ALDH1A1NPSR1HPGDKDM4EMAPT
SCHEMBL3405930 0.90 DHODH (0.48) ALDH1A1NPSR1HPGDMAPTHSD17B10
SCHEMBL3405938 0.89 DHODH (0.49) ALDH1A1HPGDMAPTHSD17B10TRPM8
SCHEMBL3398339 0.89 ALDH1A1 (0.44) ALDH1A1NPSR1HPGDKDM4EMAPT
SCHEMBL3407905 0.88 CDC7 (0.53) ALDH1A1NPSR1HPGDMAPTMAPK1
SCHEMBL3398719 0.88 KDM4E (0.47) ALDH1A1NPSR1HPGDKDM4EMAPT
SCHEMBL3401768 0.88 ALDH1A1 (0.49) ALDH1A1NPSR1HPGDKDM4EMAPT
SCHEMBL3398756 0.87 KDM4E (0.53) ALDH1A1NPSR1HPGDKDM4EMAPT
SCHEMBL3401368 0.86 KDM4E (0.52) ALDH1A1NPSR1HPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9387200-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2016-07-12 US disclosed
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2015-07-30 US disclosed
US-8952160-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2015-02-10 US disclosed
EP-2252619-B1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN INC (US) 2013-10-09 EP disclosed
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2010-12-30 US disclosed
EP-2252619-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY Fibrogen, Inc. (US) 2010-11-24 EP disclosed
WO-2009089547-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 ALDH1A1 256/4885NPSR1 3386/4885HPGD 52/4885
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 ALDH1A1 284/4885NPSR1 3289/4885HPGD 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.